Chris Halbrook News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Discover the latest techniques, cutting-edge technologies, and critical developments in cancer and immunology research

Top List: Access your free cancer and immunology resources ahead of the virtual summit Explore topics from live-cell analysis, in situ hybridization, cancer therapeutics, cell imaging, and much more 17 May 2021 To help you prepare for the upcoming SelectScience ® Virtual Cancer and Immunology Research Summit launching on Tuesday, May 11, we've pulled together a selection of the latest resources, methods, and interviews that are progressing the fields of cancer and immunology research, covering topics from next-generation cancer treatments to in situ hybridization and live-cell imaging. N...

  Now in its second year, the Virtual Cancer and Immunology Research Summit will cover major new developments in cancer and immunology research, from cutting-edge technologies to novel techniques and top resources to advance your work. Register free now to watch talks by an outstanding lineup of world-class speakers and leading manufacturers, join live Q&As and dedicated networking sessions, explore virtual resource hubs and discover the latest product launches and application news for your area of expertise. Among those invited to present will be Dr. Chris Halbrook, assistant professor at ...

Discover the scientists advancing cancer research on The Scientists' Channel Hear from cancer research experts such as Dr. Aleksandra Dukic and Dr. Gerhard Bauer on The Scientists' Channel Limiting glioblastoma invasion in the brain: Dr. Aleksandra Dukic, postdoctoral researcher at the Institute for Cancer Research, Oslo University Hospital, discusses how she is investigating novel gap junction inhibitors for use in sensitizing glioblastoma cells to chemotherapy. The incubation technology accelerating CAR-T cell therapy development: Dr. Gerhard Bauer, Professor of Hematology and Onco...

Editorial Article: Find out how metabolomics-based approaches are revealing tumor microenvironment secrets Dr. Chris Halbrook discusses how his team are exploring new methods to combat pancreatic cancer 17 Mar 2021 Dr. Chris Halbrook, assistant professor in the Department of Molecular Biology and Biochemistry at University of California, Irvine (UCI) Improving cancer survival rates is the ultimate goal for all oncologists, especially for those focusing on pancreatic cancer research. With mortality rates ranging from 5-10% within the first five years of diagnosis, early diagnosis and novel the...